{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:45:16Z","timestamp":1791089116169,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T00:00:00Z","timestamp":1311897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00436-011-2555-5","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T10:31:25Z","timestamp":1311849085000},"page":"1225-1232","source":"Crossref","is-referenced-by-count":79,"title":["Leishmania antimony resistance: what we know what we can learn from the field"],"prefix":"10.1007","volume":"109","author":[{"given":"Khatima","family":"A\u00eft-Oudhia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Gazanion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Vergnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Oury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sereno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,29]]},"reference":[{"key":"2555_CR1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0924-8579(99)90059-6","volume":"12","author":"FM Aarestrup","year":"1999","unstructured":"Aarestrup FM (1999) Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals. Int J Antimicrob Agents 12:279\u2013285","journal-title":"Int J Antimicrob Agents"},{"key":"2555_CR2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.26719\/2003.9.4.837","volume":"9","author":"MG Abdo","year":"2003","unstructured":"Abdo MG, Elamin WM, Khalil EAG, Mukhtar MM (2003) Antimony-resistant Leishmania donovani in eastern Sudan: incidence and in vitro correlation. East Mediterr Health J 9:837\u2013843","journal-title":"East Mediterr Health J"},{"key":"2555_CR3","first-page":"1","volume":"3","author":"V Adaui","year":"2010","unstructured":"Adaui V, Schnorbusch K, Zimic M, Gutierrez A, Decuypere S, Vanaerschot M, De-Doncker S, Maes L, Llanos-Cuentas A, Chappuis F, Arevalo J, Dujardin JC (2010) Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology 3:1\u201311","journal-title":"Parasitology"},{"key":"2555_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0269-7491(90)90166-A","volume":"65","author":"N Ainsworth","year":"1990","unstructured":"Ainsworth N, Cooke JA, Johnson MS (1990) Distribution of antimony in contaminated grassland: 2\u2014small mammals and invertebrates. Environ Pollut 65:79\u201387","journal-title":"Environ Pollut"},{"key":"2555_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pt.2010.12.003","volume":"4","author":"K Ait-Oudhia","year":"2011","unstructured":"Ait-Oudhia K, Gazanion E, Oury B, Vergnes B, Sereno D (2011) The fitness of antimony-resistant Leishmania parasites: lessons from the field. Trends Parasitol 4:141\u2013142","journal-title":"Trends Parasitol"},{"key":"2555_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.1169464","volume":"324","author":"NS Akopyants","year":"2009","unstructured":"Akopyants NS, Kimblin N, Secundino N, Patrick R, Peters N, Lawyer P, Dobson DE, Beverley SM, Sacks DL (2009) Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector. Science 324:265\u2013268","journal-title":"Science"},{"key":"2555_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/pgs.10.165","volume":"12","author":"T Anderson","year":"2010","unstructured":"Anderson T, Nkhoma N, Ecker A, Fidock D (2010) How can we identify parasite genes that underlie antimalarial drug resistance? Pharmacogenomics 12:59\u201385","journal-title":"Pharmacogenomics"},{"key":"2555_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4269\/ajtmh.2004.71.71","volume":"71","author":"M Antoniou","year":"2004","unstructured":"Antoniou M, Doulgerakis C, Pratlong F, Dedet JP, Tselentis Y (2004) Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum. Am J Trop Med Hyg 71:71\u201372","journal-title":"Am J Trop Med Hyg"},{"key":"2555_CR9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","volume":"56","author":"S Ashutosh","year":"2007","unstructured":"Ashutosh S, Sundar N, Goyal N (2007) Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 56:143\u2013153","journal-title":"J Med Microbiol"},{"key":"2555_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2307\/3281406","volume":"70","author":"JD Berman","year":"1984","unstructured":"Berman JD (1984) Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation. J Parasitol 70:561\u2013562","journal-title":"J Parasitol"},{"key":"2555_CR11","first-page":"197","volume":"3","author":"JD Berman","year":"1987","unstructured":"Berman JD, Gallalee JV, Best JM (1987) Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol 3:197\u2013201","journal-title":"Biochem Pharmacol"},{"key":"2555_CR12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1989.40.159","volume":"40","author":"JD Berman","year":"1989","unstructured":"Berman JD, Edwards N, King M, Grogl M (1989) Biochemistry of Pentostam resistant Leishmania. Am J Trop Med Hyg 40:159\u2013164","journal-title":"Am J Trop Med Hyg"},{"key":"2555_CR13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10661-010-1412-9","volume":"173","author":"GR Bhagure","year":"2011","unstructured":"Bhagure GR, Mirgane SR (2011) Heavy metal concentrations in groundwaters and soils of Thane Region of Maharashtra, India. Environ Monit Assess 173:643\u2013652","journal-title":"Environ Monit Assess"},{"key":"2555_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.273.5274.497","volume":"273","author":"SM Blower","year":"1996","unstructured":"Blower SM, Small PM, Hopewell PC (1996) Control strategies for tuberculosis epidemics: new models for old problems. Science 273:497\u2013500","journal-title":"Science"},{"key":"2555_CR15","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1096\/fj.09-146407","volume":"24","author":"A Bocedi","year":"2010","unstructured":"Bocedi A, Dawood KF, Fabrini R, Federici G, Gradoni L, Pedersen JZ, Ricci G (2010) Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites. FASEB J 24:1035\u20131042","journal-title":"FASEB J"},{"key":"2555_CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1476-5381.1957.tb00114.x","volume":"12","author":"E Bueding","year":"1957","unstructured":"Bueding E, Mansour JM (1957) The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni. Br J Pharmacol Chemother 12:159\u2013165","journal-title":"Br J Pharmacol Chemother"},{"key":"2555_CR17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/S0031182005008486","volume":"131","author":"KC Carter","year":"2005","unstructured":"Carter KC, Hutchison S, Boitelle A, Murray HW, Sundar S, Mullen AB (2005) Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Parasitology 131:747\u2013757","journal-title":"Parasitology"},{"key":"2555_CR18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.50.1.88-95.2006","volume":"50","author":"KC Carter","year":"2006","unstructured":"Carter KC, Hutchison S, Henriquez FL, L\u00e9gar\u00e9 D, Ouellette M, Roberts CW, Mullen AB (2006) Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase. Antimicrob Agents Chemother 50:88\u201395","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ijpara.2008.03.005","volume":"38","author":"K Choudhury","year":"2008","unstructured":"Choudhury K, Zander D, Kube M, Reinhardt R, Clos J (2008) Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII. Int J Parasitol 38:1411\u20131423","journal-title":"Int J Parasitol"},{"key":"2555_CR20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","volume":"6","author":"SL Croft","year":"2001","unstructured":"Croft SL (2001) Monitoring drug resistance in leishmaniasis. Trop Med Int Health 6:899\u2013905","journal-title":"Trop Med Int Health"},{"key":"2555_CR21","first-page":"399","volume":"123","author":"SL Croft","year":"2006","unstructured":"Croft SL, Seifert K, Yardley V (2006a) Current scenario of drug development for leishmaniasis. Indian J Med Res 123:399\u2013410","journal-title":"Indian J Med Res"},{"key":"2555_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"SL Croft","year":"2006","unstructured":"Croft SL, Sundar S, Fairlamb AH (2006b) Drug resistance in leishmaniasis. Clin Microbiol Rev 19:111\u2013126","journal-title":"Clin Microbiol Rev"},{"key":"2555_CR23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1432-1033.1995.tb20583.x","volume":"230","author":"ML Cunningham","year":"1995","unstructured":"Cunningham ML, Fairlamb AH (1995) Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. Eur J Biochem 230:460\u2013468","journal-title":"Eur J Biochem"},{"key":"2555_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1462-5822.2010.01521.x","volume":"13","author":"E Llave De La","year":"2011","unstructured":"De La Llave E, Lecoeur H, Besse A, Milon G, Prina E, Lang T (2011) A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations. Cell Microbiol 13:81\u201391","journal-title":"Cell Microbiol"},{"key":"2555_CR25","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1039\/b809186b","volume":"39","author":"C Demicheli","year":"2008","unstructured":"Demicheli C, Fr\u00e9zard F, Mangrum JB, Farrell NP (2008) Interaction of trivalent antimony with a CCHC zinc finger domain: potential relevance to the mechanism of action of antimonial drugs. Chem Commun (Camb) 39:4828\u20134830","journal-title":"Chem Commun (Camb)"},{"key":"2555_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1042\/BJ20040283","volume":"381","author":"H Denton","year":"2004","unstructured":"Denton H, McGregor JC, Coombs GH (2004) Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDR1. Biochem 381:405\u2013412","journal-title":"Biochem"},{"key":"2555_CR27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1146\/annurev.mi.46.100192.003403","volume":"46","author":"AH Fairlamb","year":"1992","unstructured":"Fairlamb AH, Cerami A (1992) Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 46:695\u2013729","journal-title":"Annu Rev Microbiol"},{"key":"2555_CR28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.41.4.827","volume":"41","author":"F Faraut-Gambarelli","year":"1997","unstructured":"Faraut-Gambarelli F, Piarroux R, Deniau M, Giusiano B, Marty P, Michel G, Faug\u00e8re B, Dumon H (1997) In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob Agents Chemother 41:827\u2013830","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR29","first-page":"149","volume":"67","author":"F Gambarelli","year":"1987","unstructured":"Gambarelli F, Franck J, Dumon H (1987) Sensibilit\u00e9 des Leishmania spp aux derives stibi\u00e8s. Utilisation de macrophages p\u00e9riton\u00e9aux de souris. Ann Soc Belge Med Trop 67:149\u2013155","journal-title":"Ann Soc Belge Med Trop"},{"key":"2555_CR30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0001-706X(92)90042-V","volume":"51","author":"A Gebre-Hiwot","year":"1992","unstructured":"Gebre-Hiwot A, Tadesse G, Croft SL, Frommel D (1992) An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1. Acta Trop 51:237\u2013245","journal-title":"Acta Trop"},{"key":"2555_CR31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbiopara.2007.11.008","volume":"158","author":"PA Genest","year":"2008","unstructured":"Genest PA, Haimeur A, L\u00e9gar\u00e9 D, Sereno D, Roy G, Messier N, Papadopoulou B, Ouellette M (2008) A protein of the leucine-rich repeats (LRRs) superfamily is implicated in antimony resistance in Leishmania infantum amastigotes. Mol Biochem Parasitol 158:95\u201399","journal-title":"Mol Biochem Parasitol"},{"key":"2555_CR32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0035-9203(95)90572-3","volume":"89","author":"LG Goodwin","year":"1995","unstructured":"Goodwin LG (1995) Pentostam (sodium stibogluconate); a 50-year personal r\u00e9miniscence. Trans R Soc Trop Med Hyg 89:39\u2013341","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2555_CR33","doi-asserted-by":"crossref","first-page":"31010","DOI":"10.1074\/jbc.M403959200","volume":"279","author":"B Gourbal","year":"2004","unstructured":"Gourbal B, Sonuc N, Bhattacharjee H, L\u00e9gar\u00e9 D, Sundar S, Ouellette M, Rosen BP, Mukhopadhyay R (2004) Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J Biol Chem 279:31010\u201331017","journal-title":"J Biol Chem"},{"key":"2555_CR34","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/AAC.01075-08","volume":"52","author":"DA Goyeneche-Patino","year":"2008","unstructured":"Goyeneche-Patino DA, Valderrama L, Walker J, Saravia NG (2008) Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis. Antimicrob Agents Chemother 52:4503\u20134506","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR35","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/emboj\/16.11.3057","volume":"16","author":"K Grondin","year":"1997","unstructured":"Grondin K, Haimeur A, Mukhopadhyay R, Rosen BP, Ouellette M (1997) Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 16:3057\u20133065","journal-title":"EMBO J"},{"key":"2555_CR36","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1093\/nar\/gkg806","volume":"31","author":"C Guimond","year":"2003","unstructured":"Guimond C, Trudel N, Brochu C, Marquis N, El-Fadili A, Peytavi R, Briand G, Richard D, Messier N, Papadopoulou B, Corbeil J, Bergeron MG, L\u00e9gar\u00e9 D, Ouellette M (2003) Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res 31:5886\u20135896","journal-title":"Nucleic Acids Res"},{"key":"2555_CR37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1471-4922(00)01811-0","volume":"17","author":"N Gupta","year":"2001","unstructured":"Gupta N, Goyal N, Rastogi AK (2001) In vitro cultivation and characterization of axenic amastigotes of Leishmania. Trends Parasitol 17:150\u2013153","journal-title":"Trends Parasitol"},{"key":"2555_CR38","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1371\/journal.pmed.0030162","volume":"3","author":"R Hadighi","year":"2006","unstructured":"Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M (2006) Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med 3:e162","journal-title":"PLoS Med"},{"key":"2555_CR39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1365-2958.1999.01634.x","volume":"34","author":"A Haimeur","year":"1999","unstructured":"Haimeur A, Guimond C, Pilote S, Mukhopadhyay R, Rosen BP, Poulin R, Ouellette M (1999) Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol 34:726\u2013735","journal-title":"Mol Microbiol"},{"key":"2555_CR40","doi-asserted-by":"crossref","first-page":"e1000907","DOI":"10.1371\/journal.ppat.1000907","volume":"6","author":"AK Haldar","year":"2010","unstructured":"Haldar AK, Yadav V, Singhal E, Bisht KK, Singh A, Bhaumik S, Basu R, Sen P, Roy S (2010) Leishmania donovani isolates with antimony-resistant but not sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. PLoS Pathog 6:e1000907","journal-title":"PLoS Pathog"},{"key":"2555_CR41","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1128\/AAC.49.10.4406-4409.2005","volume":"49","author":"P Holzmuller","year":"2005","unstructured":"Holzmuller P, Sereno D, Lemesre JL (2005) Lower nitric oxide susceptibility of trivalent antimony-resistant amastigotes of Leishmania infantum. Antimicrob Agents Chemother 49:4406\u20134409","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR42","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1039\/b411474d","volume":"7","author":"M Krachler","year":"2005","unstructured":"Krachler M, Zheng J, Koerner R, Zdanowicz C, Fisher D, Shotyk W (2005) Increasing atmospheric antimony contamination in the northern hemisphere: snow and ice evidence from Devon Island, Arctic Canada. J Environ Monit 7:169\u20131176","journal-title":"J Environ Monit"},{"key":"2555_CR43","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","volume":"53","author":"D Kumar","year":"2009","unstructured":"Kumar D, Kulshrestha A, Singh R, Salotra P (2009) In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrob Agents Chemother 53:835\u2013838","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2010.03716.x","volume":"70","author":"A Kumar","year":"2010","unstructured":"Kumar A, Sisodia B, Misra P, Sundar S, Shasany AK, Dube A (2010) Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani. Br J Clin Pharmacol 70:609\u2013617","journal-title":"Br J Clin Pharmacol"},{"key":"2555_CR45","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/595710","volume":"48","author":"L Lachaud","year":"2009","unstructured":"Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M (2009) Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum. Clin Infect Dis 48:e16\u2013e22","journal-title":"Clin Infect Dis"},{"key":"2555_CR46","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pt.2009.07.006","volume":"25","author":"T Lang","year":"2009","unstructured":"Lang T, Lecoeur H, Prina E (2009) Imaging Leishmania development in their host cells. Trends Parasitol 25:464\u2013473","journal-title":"Trends Parasitol"},{"key":"2555_CR47","doi-asserted-by":"crossref","first-page":"26301","DOI":"10.1074\/jbc.M102351200","volume":"276","author":"D L\u00e9gar\u00e9","year":"2001","unstructured":"L\u00e9gar\u00e9 D, Richard D, Mukhopadhyay R, Stierhof YD, Rosen BP, Haimeur A, Papadopoulou B, Ouellette M (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 276:26301\u201326307","journal-title":"J Biol Chem"},{"key":"2555_CR48","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1128\/AAC.01474-08","volume":"53","author":"P Leprohon","year":"2009","unstructured":"Leprohon P, L\u00e9gar\u00e9 D, Ouellette M (2009a) Intracellular localization of the ABCC proteins of Leishmania and their role in resistance to antimonials. Antimicrob Agents Chemother 53:2646\u201326499","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR49","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/nar\/gkn1069","volume":"37","author":"P Leprohon","year":"2009","unstructured":"Leprohon P, L\u00e9gar\u00e9 D, Raymond F, Madore E, Hardiman G, Corbeil J, Ouellette M (2009b) Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res 37:1387\u20131399","journal-title":"Nucleic Acids Res"},{"key":"2555_CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00436-010-1852-8","volume":"107","author":"DB Liarte","year":"2010","unstructured":"Liarte DB, Murta SM (2010) Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four new world Leishmania species. Parasitol Res 107:205\u2013212","journal-title":"Parasitol Res"},{"key":"2555_CR51","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","volume":"180","author":"R Lira","year":"1999","unstructured":"Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180:564\u2013567","journal-title":"J Infect Dis"},{"key":"2555_CR52","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","volume":"46","author":"A Llanos-Cuentas","year":"2008","unstructured":"Llanos-Cuentas A, Tulliano G, Araujo-Castillo R, Miranda-Verastegui C, Santamaria-Castrellon G, Ramirez L, Lazo M, De-Doncker S, Boelaert M, Robays J, Dujardin JC, Arevalo J, Chappuis F (2008) Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis 46:223\u2013231","journal-title":"Clin Infect Dis"},{"key":"2555_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.2008.79.69","volume":"79","author":"M Maharjan","year":"2008","unstructured":"Maharjan M, Singh S, Chatterjee M, Madhubala R (2008) Role of aquaglycoprotein (AQP-1) gene and drug uptake in antimony-resistant isolates of Leishmania donovani. Am J Trop Med Hyg 79:69\u201375","journal-title":"Am J Trop Med Hyg"},{"key":"2555_CR54","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1017\/S0031182007003150","volume":"134","author":"G Mandal","year":"2007","unstructured":"Mandal G, Wyllie S, Singh N, Sundar S, Fairlamb AH, Chatterjee M (2007) Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology 134:1679\u20131687","journal-title":"Parasitology"},{"key":"2555_CR55","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/jac\/dkp468","volume":"65","author":"S Mandal","year":"2010","unstructured":"Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R (2010) Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and resistant clinical isolates of Leishmania donovani from India. J Antimicrob Chemother 65:496\u2013507","journal-title":"J Antimicrob Chemother"},{"key":"2555_CR56","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1365-2958.2005.04782.x","volume":"57","author":"N Marquis","year":"2005","unstructured":"Marquis N, Gourbal B, Rosen BP, Mukhopadhyay R, Ouellette M (2005) Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania. Mol Microbiol 57:1690\u20131699","journal-title":"Mol Microbiol"},{"key":"2555_CR57","doi-asserted-by":"crossref","first-page":"681","DOI":"10.4269\/ajtmh.2007.76.681","volume":"76","author":"MK Mittal","year":"2007","unstructured":"Mittal MK, Rai S, Ravinder A, Gupta S, Sundar S, Goyal N (2007) Characterization of natural antimony r\u00e9sistance in Leishmania donovani isolates. Am J Trop Med Hyg 76:681\u2013688","journal-title":"Am J Trop Med Hyg"},{"key":"2555_CR58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1586\/eri.10.78","volume":"8","author":"S Mondal","year":"2010","unstructured":"Mondal S, Bhattacharya P, Ali N (2010) Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther 8:919\u2013944","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2555_CR59","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1371\/journal.pntd.0001167","volume":"5","author":"RL Monte-Neto","year":"2011","unstructured":"Monte-Neto RL, Coelho AC, Raymond F, L\u00e9gar\u00e9 D, Corbeil J, Melo MN, Fr\u00e9zard F, Ouellette M (2011) Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis. PLoS Negl Trop Dis 5:e1167","journal-title":"PLoS Negl Trop Dis"},{"key":"2555_CR60","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","volume":"50","author":"J Mookerjee-Basu","year":"2006","unstructured":"Mookerjee-Basu J, Mookerjee A, Sen P, Bhaumik S, Sen P, Banerjee S, Naskar K, Choudhuri SK, Saha B, Raha S, Roy S (2006) Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob Agents Chemother 50:1788\u20131797","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR61","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/jac\/dkl494","volume":"59","author":"A Mukherjee","year":"2007","unstructured":"Mukherjee A, Padmanabhan PK, Singh S, Roy G, Girard I, Chatterjee M, Ouellette M, Madhubala R (2007) Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani. J Antimicrob Chemother 59:204\u2013211","journal-title":"J Antimicrob Chemother"},{"key":"2555_CR62","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2217\/fmb.10.92","volume":"5","author":"MW Murray","year":"2010","unstructured":"Murray MW (2010) Treatment of visceral leishmaniasis in 2010: direction from Bihar state, India. Future Microbiol 5:1301\u20131303","journal-title":"Future Microbiol"},{"key":"2555_CR63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","volume":"29","author":"S Natera","year":"2007","unstructured":"Natera S, Machuca C, Padren-Nieves M, Romero A, Diaz E, Ponte-Sucre A (2007) Leishmania spp.: proficiency of drug-resistant parasites. Int J Antimicrob Agents 29:637\u2013642","journal-title":"Int J Antimicrob Agents"},{"key":"2555_CR64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1368-7646(98)80213-6","volume":"1","author":"M Ouellette","year":"1998","unstructured":"Ouellette M, L\u00e9gar\u00e9 D, Haimeur A, Grondin K, Roy G, Brochu C, Papadopoulou B (1998) ABC transporters in Leishmania and their role in drug resistance. Drug Resist Update 1:43\u201348","journal-title":"Drug Resist Update"},{"key":"2555_CR65","doi-asserted-by":"crossref","first-page":"35853","DOI":"10.1074\/jbc.M204403200","volume":"277","author":"SL Oza","year":"2002","unstructured":"Oza SL, Tetaud E, Ariyanayagam MR, Warnon SS, Fairlamb AH (2002) A single enzyme catalyses formation of trypanothione from glutathione and spermidine in Trypanosoma cruzi. J Biol Chem 277:35853\u201335861","journal-title":"J Biol Chem"},{"key":"2555_CR66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2307\/3285647","volume":"85","author":"SM Robledo","year":"1999","unstructured":"Robledo SM, Valencia AZ, Saravia NG (1999) Sensitivity to Glucantime of Leishmania viannia isolated from patients prior to treatment. J Parasitol 85:360\u2013366","journal-title":"J Parasitol"},{"key":"2555_CR67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1515\/JBCPP.1995.6.3-4.251","volume":"6","author":"BP Rosen","year":"1995","unstructured":"Rosen BP (1995) Resistance mechanisms to arsenicals and antimonials. J Basic Clin Physio Pharmacol 6:251\u2013263","journal-title":"J Basic Clin Physio Pharmacol"},{"key":"2555_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-008-0943-2","volume":"103","author":"DO Santos","year":"2008","unstructured":"Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, Bernardino A, Bourguignon SC, Corte-Real S, Pinho RT, Rodrigues CR, Castro HC (2008) Leishmaniasis treatment\u2014a challenge that remains: a review. Parasitol Res 103:1\u201310","journal-title":"Parasitol Res"},{"key":"2555_CR69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.a.21001","volume":"79","author":"A Sarkar","year":"2011","unstructured":"Sarkar A, Saha P, Mandal G, Mukhopadhyay D, Roy S, Singh SK, Das S, Goswami RP, Saha B, Kumar D, Das P, Chatterjee M (2011) Monitoring of intracellular nitric oxide in leishmaniasis: its applicability in patients with visceral leishmaniasis. Cytometry 79:35\u201345","journal-title":"Cytometry"},{"key":"2555_CR70","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/jac\/dkp500","volume":"65","author":"K Seifert","year":"2010","unstructured":"Seifert K, Escobar P, Croft SL (2010) In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent. J Antimicrob Chemother 65:508\u2013511","journal-title":"J Antimicrob Chemother"},{"key":"2555_CR71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s004360050272","volume":"83","author":"D Sereno","year":"1997","unstructured":"Sereno D, Lemesre JL (1997) Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro. Parasitol Res 83:401\u2013403","journal-title":"Parasitol Res"},{"key":"2555_CR72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","volume":"56","author":"D Sereno","year":"2007","unstructured":"Sereno D, Cordeiro da Silva A, Mathieu-Daude F, Ouaissi A (2007) Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol Int 56:3\u20137","journal-title":"Parasitol Int"},{"key":"2555_CR73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1039\/b515468p","volume":"7","author":"W Shotyk","year":"2005","unstructured":"Shotyk W, Krachler M, Chen B (2005a) Antimony: global environmental contaminant. J Environ Monit 7:1135\u20131136","journal-title":"J Environ Monit"},{"key":"2555_CR74","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1039\/b509352j","volume":"7","author":"W Shotyk","year":"2005","unstructured":"Shotyk W, Krachler M, Chen B, Zheng J (2005b) Natural abundance of Sb and Sc in pristine groundwaters, Springwater township, Ontario, Canada, and implications for tracing contamination from landfill leachates. J Environ Monit 7:1238\u20131244","journal-title":"J Environ Monit"},{"key":"2555_CR75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijantimicag.2010.03.012","volume":"36","author":"R Singh","year":"2010","unstructured":"Singh R, Kumar D, Duncan RC, Nakhasi HL, Salotra P (2010) Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Int J Antimicrob Agents 36:50\u201357","journal-title":"Int J Antimicrob Agents"},{"key":"2555_CR76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2334-10-209","volume":"10","author":"AS Souza","year":"2010","unstructured":"Souza AS, Giudice A, Pereira JM, Guimaraes LM, De-Jesus AR, De-Moura TR, Wilson ME, Carvalho EM, Almeida RP (2010) Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect Dis 10:209","journal-title":"BMC Infect Dis"},{"key":"2555_CR77","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.2001.65.193","volume":"65","author":"S Sundar","year":"2001","unstructured":"Sundar S, Pai K, Kumar R, Pathak-Tripathi K, Gam AA, Ray M, Kenney RT (2001) Resistance to treatment in kala-azar: speciation of isolates from northeast India. Am J Trop Med Hyg 65:193\u2013196","journal-title":"Am J Trop Med Hyg"},{"key":"2555_CR78","doi-asserted-by":"crossref","first-page":"e904","DOI":"10.1371\/journal.pntd.0000904","volume":"4","author":"R t'Kindt","year":"2010","unstructured":"t'Kindt R, Scheltema RA, Jankevics A, Brunker K, Rijal S, Dujardin JC, Breitling R, Watson DG, Coombs GH, Decuyper S (2010) Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl Trop Dis 4:e904","journal-title":"PLoS Negl Trop Dis"},{"key":"2555_CR79","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.meegid.2010.05.006","volume":"10","author":"DC Torres","year":"2010","unstructured":"Torres DC, Adaui V, Ribeiro-Alves M, Romero GA, Ar\u00e9valo J, Cupolillo E, Dujardin JC (2010) Targeted gene expression profiling in Leishmania braziliensis and Leishmania guyanensis parasites isolated from Brazilian patients with different antimonial treatment outcomes. Infect Genet Evol 10:727\u2013733","journal-title":"Infect Genet Evol"},{"key":"2555_CR80","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2008-9-7-r115","volume":"9","author":"JM Ubeda","year":"2008","unstructured":"Ubeda JM, L\u00e9gar\u00e9 D, Raymond F, Ouameur AA, Boisvert S, Rigault P, Corbeil J, Tremblay MJ, Olivier M, Papadopoulou B, Ouellette M (2008) Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol 9:R115","journal-title":"Genome Biol"},{"key":"2555_CR81","doi-asserted-by":"crossref","first-page":"e12211","DOI":"10.1371\/journal.pone.0012211","volume":"5","author":"M Vanaerschot","year":"2010","unstructured":"Vanaerschot M, Maes L, Ouakad M, Adaui V, Maes L, De Doncker S, Rijal S, Chappuis F, Dujardin JC, Decuypere S (2010) Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS One 5:e12211","journal-title":"PLoS One"},{"key":"2555_CR82","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","volume":"12","author":"V Vanlerberghe","year":"2007","unstructured":"Vanlerberghe V, Diap G, Guerin JP, Meheus F, Gerstl S, Van der Stuyft P, Boelaert M (2007) Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Trop Med Int Health 12:274\u2013283","journal-title":"Trop Med Int Health"},{"key":"2555_CR83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/mcp.M600319-MCP200","volume":"6","author":"B Vergnes","year":"2007","unstructured":"Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6:88\u2013101","journal-title":"Mol Cell Proteomics"},{"key":"2555_CR84","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","volume":"53","author":"M Vermeersch","year":"2009","unstructured":"Vermeersch M, da Luz RI, Tot\u00e9 K, Timmermans JP, Cos P, Maes L (2009) In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences. Antimicrob Agents Chemother 53:3855\u20133859","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR85","doi-asserted-by":"crossref","unstructured":"Walker J, Saravia NG (2004) Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents. J Parasitol 90:1155\u201362","DOI":"10.1645\/GE-3347"},{"key":"2555_CR86","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pt.2005.04.007","volume":"21","author":"PE Wilson","year":"2005","unstructured":"Wilson PE, Alker AP, Meshnick SR (2005) Real-time PCR methods for monitoring antimalarial drug resistance. Trends Parasitol 21:278\u2013283","journal-title":"Trends Parasitol"},{"key":"2555_CR87","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","volume":"279","author":"S Wyllie","year":"2004","unstructured":"Wyllie S, Cunningham ML, Fairlamb AH (2004) Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J Biol Chem 279:39925\u201339932","journal-title":"J Biol Chem"},{"key":"2555_CR88","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/AAC.01563-07","volume":"52","author":"S Wyllie","year":"2008","unstructured":"Wyllie S, Vickers TJ, Fairlamb AH (2008) Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials. Antimicrob Agents Chemother 52:359\u2013365","journal-title":"Antimicrob Agents Chemother"},{"key":"2555_CR89","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbiopara.2010.05.015","volume":"173","author":"S Wyllie","year":"2010","unstructured":"Wyllie S, Mandal G, Singh N, Sundar S, Fairlamb AH, Chatterjee M (2010) Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates. Mol Biochem Parasitol 173:162\u2013164","journal-title":"Mol Biochem Parasitol"},{"key":"2555_CR90","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1086\/507710","volume":"194","author":"V Yardley","year":"2006","unstructured":"Yardley V, Ortuno N, Llanos-Cuentas A, Chappuis F, Doncker SD, Ramirez L, Croft S, Arevalo J, Adaui V, Bermudez H, Decuypere S, Dujardin JC (2006) American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility? J Infect Dis 194:1168\u20131175","journal-title":"J Infect Dis"},{"key":"2555_CR91","doi-asserted-by":"crossref","first-page":"37445","DOI":"10.1074\/jbc.M404383200","volume":"279","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Messier N, Ouellette M, Rosen BP, Mukhopadhyay R (2004) Leishmania major LmACR2 is a pentavalent antimony reductase that confer sensitivity to the drug Pentostam. J Biol Chem 279:37445\u201337451","journal-title":"J Biol Chem"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-011-2555-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-011-2555-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-011-2555-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T02:31:45Z","timestamp":1638153105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-011-2555-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,29]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["2555"],"URL":"https:\/\/doi.org\/10.1007\/s00436-011-2555-5","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,29]]}}}